Friday, April 19, 2024
Home Biotech News Infections Page 2

Infections

    Featured posts
    Issam Radd

    Citius (CTXR): Halt For Superiority On The Horizon? (SeekingAlpha).

    2021 Watch List Editor / Curator -
    Jun. 15, 2021 10:41 AM ET Citius Pharmaceuticals, Inc. (CTXR) Summary
    Biotech Stock Review. Citius, CTXR

    More Great News From Citius Pharma (CTXR).

    Incubator Editor / Curator -
    UPDATED CHART 6-15-21 Mino-Lok® Phase III, FDA NewsRussell 2000 Index NewsTechnical Breakout News
    Auris Medical, Altamira Therapeutics

    Adding Auris Medical (EARS) $3.50 to Biotech Watch List.

    Biotech News Editor / Curator -
    Auris Medical soared 590% in one Week on Covid Related News on December 1st, 2020. LIFT OFF...
    Aphex Biocleanse Systems

    Aphex BioCleanse Further Expands Distribution Channels.

    Superbug News - CoronaVirus Watch List Editor / Curator -
    Aphex BioCleanse Systems Announces Partnership With Bifulco Consulting Group to Expand Distribution Channels PITTSFORD, N.Y., May 20, 2021...

    Citius Pharma (CTXR) Updates Shareholders.

    CoronaVirus Editor / Curator -
    Citius Update Stem Cell Study Citius Pharmaceuticals, Inc announced that it will present a poster at the International Society...
    Dermaphex

    Aphex BioCleanse System’s (SNST) Significant Hand Sanitizer Purchase Order.

    Superbug News - CoronaVirus Watch List Editor / Curator -
    Aphex BioCleanse Systems Announces Significant Purchase Order for Proprietary, Alcohol-Free Hand Sanitizer Product PITTSFORD, N.Y. , May 4, 2021 /PRNewswire/ -- Aphex...

    Stem Cell Play Organicell (BPSR) Screams Higher.

    Infections Editor / Curator -
    Stock Levitates After Series of Positive Press Releases on Zofrin. Added to the Watch List in April a...
    Citius, Leonard Mazur

    Interview: Citius Pharma (CTXR) $1.74, Chairman Leonard Mazur.

    Infections Editor / Curator -
    https://youtu.be/vMIy8xWLOKI?t=3699 Starts at 1 Hour Mark. INSIDER HOLDINGS
    Citius, Biotech Stock Review

    Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.

    Infections Editor / Curator -
    The 2021 Biotech Six Pack, Six Stocks We Expect to Double. We're still putting the 2021 list together now,...

    Make Hay While the Sun Shines. Up 6,400%.

    Biotech News Editor / Curator -
    Celcius (CELH) We're Up 6,400%. Alkaline Water (WTER) We're Up 12%.Dicerna (DRNA) We're Up 700%. Ready to Breakout?BioSig (BSGM) We Have...
    123...9Page 2 of 9

    Latest article

    Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

    All News Editor / Curator -
    Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...

    Major Mpox Outbreak in the Democratic Republic of Congo.

    Mpox Editor / Curator -
    As Reported in NPR's Gates and Soda Major Mpox Outbreak in the Democratic Republic of Congo is a...

    Mpox Infections Rise to Almost Double Last Year’s Numbers.

    All News Editor / Curator -
    The number of mpox cases in 2024 is already nearly double the number of cases that were detected in all of...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.